Back to search results

Promoting Active Living for Metastatic Breast Cancer

This study is looking at a program called "Acceptance- and mindfulness-based physical activity promotion" for people with metastatic breast cancer (cancer that has spread to other parts of the body). This program aims to help you be more active and improve your overall well-being. It includes a wearable activity tracker and techniques to help you stay active over 8-12 weeks. To join, you need to be at least 18 years old, have metastatic breast cancer, and have your doctor's approval to participate. The study will look at how easy the program is to use and how helpful participants find it. There are 38 people planned for this study, but its current status is unclear.

Study design
This is a single-group study with 38 participants. It will look at changes before and after the program.
What's involved
You would participate in the program for up to 8-12 weeks, which includes using a wearable physical activity tracker.
Compensation
Not stated in the trial record.
Follow-up
Your experience will be measured at Week 9 after starting the program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07238023

Promoting Active Living Among People With Metastatic Breast Cancer

Recruiting
NAAges 18–99InterventionalSupportive care
University of Oklahoma
~38 participants
Updated 2026-07-30 on ClinicalTrials.gov
What's tested:Acceptance- and mindfulness-based physical activity promotion

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Semi-structured Interviews
Measured over Week 9
+7 more outcomes measured

Conditions

Metastatic Invasive Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
Oklahoma1

Study leadership

  • Michael C Robertson, MPH, PhD · PRINCIPAL_INVESTIGATOR · University of Oklahoma

Who to contact

Michael C Robertson, PhD, MPH
[email protected]
14052718001 · ext. 33145
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

having been diagnosed with metastatic breast cancer
medical clearance from healthcare provider to participate in this study
life expectancy of at least 6 months as per the participant's healthcare provider
Eastern Cooperative Oncology Group performance status of or 0 or 1
being willing and able to use a smartphone and web interface with or without assistance; if assistance is needed, it must be readily available
adequate visual and hearing acuity to use a smartphone and web interface as indicated by self-report
adequate motor capacity to use a smartphone and web interface as indicated by self-report
willingness to download and use study-specific app(s), the Fitbit mobile application (this requires use of a Google Gmail account), and other mobile applications for study purposes as needed
completed baseline survey

Exclusion

contraindications to physical activity (e.g., uncontrolled hypertension or cardiac disease noted by the patient's treating healthcare provider)
presence of bone metastases deemed unstable by the treating healthcare provider.
untreated brain metastases
history of dementia or other major neurocognitive disorder
received a diagnosed of Major Depressive Disorder within the previous 6 months
received a diagnosis of a major psychiatric conditions such as bipolar disorder, psychosis, schizophrenia, or alcoholism that could affect the ability to understand and/or complete the study
currently hospitalized
enrolled in hospice
inability to speak, read, and write in English at the 7th grade level

What this trial measures

  • Semi-structured InterviewsWeek 9

    Semi-structured interviews will be used to assess participants' overall experience and their perceptions of the usability, usefulness, and enjoyability of the intervention.

  • Perceived ease of useWeek 9

    Face valid questions will be used to determine whether participants found the interventions easy to use. The face valid questions consists of five 7-point Likert-type items. Responses range from "Not At All Easy" (scored as 1) to "Very Easy" (scored as 7). Higher scores reflect greater ease of use.

  • Perceived UsefulnessWeek 9

    Face valid questions will be used to determine whether participants found the interventions useful. The face valid questions consists of five 7-point Likert-type items. Responses range from "Not At All Useful" (scored as 1) to "Very Useful" (scored as 7). Higher scores reflect greater perceived usefulness.

  • Enjoyability - Face Valid QuestionsWeek 9

    Face valid questions will be used to assess the enjoyability of the interventions in this study. The face valid questions consists of five 7-point Likert-type items. Responses range from "Not At All Enjoyable" (scored as 1) to "Very Enjoyable" (scored as 7). Higher scores reflect greater enjoyability.

  • Enjoyability - Interest/Enjoyment SubscaleWeek 9

    The interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMIe) will be used to assess the enjoyability of the interventions in this study. The IMIe sub-scale consists of seven 7-point Likert-type items. Responses range from "Not At All True" (scored as 1) to "Very True" (scored as 7). Higher scores reflect greater enjoyability.

  • Feasibility of the Program - Study RetentionWeek 9

    We will assess program feasibility via measurements of study retention. We will compute what percentage of enrolled participant complete post-intervention data collection procedures.

  • Feasibility of the Program - AdherenceWeek 9

    We will assess program feasibility via measurements of intervention adherence. We will compute what percentage of participants engage with at least 75% of the intervention modules.

  • Feasibility of Collecting Biological SamplesWeek 9

    We will assess the feasibility of assessing gene expression in the present context by assessing what percentage of enrolled participants provide analyzable data in optional post-intervention blood draws.